<DOC>
	<DOCNO>NCT01535196</DOCNO>
	<brief_summary>The investigator hypothesize vitamin D deficiency 25-OH-D3 vitamin substitution improve heart function chronic heart failure . Type study : Controlled , randomize , double blind , placebo control Number patient : 300 ; 150 treat 150 placebo control Type drug : 180 000 IU 25-OH-D3 vitamin oil ( Vigantol ) per month 0,1,2,3,6 , month Duration study:1+1 year Primary end point : Survival rate , Ejection fraction ultrasound , Brain natriuretic peptid , Secondary end point : Safety D-vitamin supplementation , well score , blood pressure , BMI Walking distant 6 minute Visits : Screening , Randomization , 1month , 2 month , 3 month , 6 month , 12 month , 24 month ,</brief_summary>
	<brief_title>Vitamine D Treatment Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>NYHA IIIV vitamin D level 1030 ng/ml ejection fraction ultrasound &lt; 40 % blood calcium &gt; 2,6 mmol/l urinary calcium &gt; 0,1 mmol/body weight kg/die blood phosphorus &gt; 1,45 mmol/l nephrolithiasis history GFR &lt; 30 ml/min vitamin D injection last 6 month actual 1,25OH2D3 vitamin treatment Myocardial infarction serious coronaria stenosis anamnesis uncontrolled atrial fibrillation serious valve disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>heart failure</keyword>
</DOC>